Manufacturers Life Insurance Company, The Atara Biotherapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $103 Billion
- Q1 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Atara Biotherapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 312,163 shares of ATRA stock, worth $2.41 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
312,163
Previous 25,174
1140.02%
Holding current value
$2.41 Million
Previous $12,000
1691.67%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding ATRA
# of Institutions
87Shares Held
85MCall Options Held
18.4KPut Options Held
51.3K-
Eco R1 Capital, LLC San Francisco, CA10.2MShares$78.4 Million0.2% of portfolio
-
Redmile Group, LLC San Francisco, CA9.26MShares$71.4 Million0.25% of portfolio
-
Black Rock Inc. New York, NY6.83MShares$52.7 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC6.58MShares$50.7 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il6.51MShares$50.2 Million0.0% of portfolio
About Atara Biotherapeutics, Inc.
- Ticker ATRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,362,304
- Market Cap $728M
- Description
- Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...